Richard W. Compans

Active 1966–2025

150
Papers
23,889
Citations
95
h-index
149
i10-index

Citations

Citations per year for Richard W. Compans1967: 4 citations1968: 5 citations1969: 13 citations1970: 19 citations1971: 34 citations1972: 39 citations1973: 63 citations1974: 72 citations1975: 75 citations1976: 62 citations1977: 70 citations1978: 40 citations1979: 40 citations1980: 73 citations1981: 52 citations1982: 34 citations1983: 56 citations1984: 34 citations1985: 50 citations1986: 31 citations1987: 42 citations1988: 38 citations1989: 52 citations1990: 30 citations1991: 34 citations1992: 40 citations1993: 60 citations1994: 58 citations1995: 67 citations1996: 78 citations1997: 80 citations1998: 110 citations1999: 99 citations2000: 130 citations2001: 102 citations2002: 111 citations2003: 114 citations2004: 130 citations2005: 107 citations2006: 71 citations2007: 95 citations2008: 116 citations2009: 127 citations2010: 222 citations2011: 292 citations2012: 351 citations2013: 262 citations2014: 249 citations2015: 221 citations2016: 213 citations2017: 193 citations2018: 217 citations2019: 674 citations2020: 696 citations2021: 660 citations2022: 400 citations2023: 343 citations2024: 383 citations2025: 204 citations2026: 3 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,052 citing papers, 38.3% of this breakdownChina: 685 citing papers, 8.6% of this breakdownUnited Kingdom: 488 citing papers, 6.1% of this breakdownGermany: 364 citing papers, 4.6% of this breakdownAustralia: 250 citing papers, 3.1% of this breakdownCanada: 250 citing papers, 3.1% of this breakdownJapan: 240 citing papers, 3% of this breakdownFrance: 234 citing papers, 2.9% of this breakdownSouth Korea: 198 citing papers, 2.5% of this breakdownNetherlands: 183 citing papers, 2.3% of this breakdownIndia: 166 citing papers, 2.1% of this breakdownSwitzerland: 152 citing papers, 1.9% of this breakdown
0%38.3%Other 21.5%

Fields

  • Medicine46.2%
  • Immunology and Microbiology19.2%
  • Biochemistry, Genetics and Molecular Biology14.2%
  • Pharmacology, Toxicology and Pharmaceutics12.9%
  • Agricultural and Biological Sciences2.7%
  • Environmental Science1.6%
  • Other3.2%

Topics

  • Influenza Virus Research Studies7.8%
  • Respiratory viral infections research5.1%
  • Advancements in Transdermal Drug Delivery4.5%
  • Immunotherapy and Immune Responses4%
  • Immune Cell Function and Interaction3.5%
  • Virus-based gene therapy research3%
  • Other72.1%

Coauthors

All papers

Open in search
  1. Dissolving polymer microneedle patches for influenza vaccination

    Authors: , , , , , , , , , - Nature Medicine 2010 cited by 924

  2. The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , - The Lancet 2017 cited by 424

  3. NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?

    Authors: , , , , , , , , , - mBio 2018 cited by 307

  4. Programming the magnitude and persistence of antibody responses with innate immunity

    Authors: , , , , , , , , , , , , , , , , , - Nature 2011 cited by 979

  5. Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2011 cited by 802

  6. Critical role for the chemokine receptor CXCR6 in NK cell–mediated antigen-specific memory of haptens and viruses

    Authors: , , , , , , , , , , - Nature Immunology 2010 cited by 684

  7. Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity

    Authors: , , , , - Journal of Controlled Release 2009 cited by 251

  8. Long-term stability of influenza vaccine in a dissolving microneedle patch

    Authors: , , , , , , - Drug Delivery and Translational Research 2016 cited by 146

  9. Characterization of temperature sensitive influenza virus mutants defective in neuraminidase

    Authors: , , , - Virology 1974 cited by 796

  10. Identification of α-Dystroglycan as a Receptor for Lymphocytic Choriomeningitis Virus and Lassa Fever Virus

    Authors: , , , , , , , , , - Science 1998 cited by 711

  11. Double-layered protein nanoparticles induce broad protection against divergent influenza A viruses

    Authors: , , , , , , , , , - Nature Communications 2018 cited by 191

  12. Enhanced Stability of Inactivated Influenza Vaccine Encapsulated in Dissolving Microneedle Patches

    Authors: , , , , , - Pharmaceutical Research 2015 cited by 94

  13. Original Antigenic Sin Responses to Influenza Viruses

    Authors: , , , - The Journal of Immunology 2009 cited by 273

  14. Enhanced Immunogenicity of Stabilized Trimeric Soluble Influenza Hemagglutinin

    Authors: , , , , , - PLoS ONE 2010 cited by 129

  15. Host Responses from Innate to Adaptive Immunity after Vaccination: Molecular and Cellular Events

    Authors: , - Molecules and Cells 2009 cited by 79

  16. Intranasal vaccination with influenza HA/GO-PEI nanoparticles provides immune protection against homo- and heterologous strains

    Authors: , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2021 cited by 71

  17. Virus-like Particles Containing Multiple M2 Extracellular Domains Confer Improved Cross-protection Against Various Subtypes of Influenza Virus

    Authors: , , , , , , - Molecular Therapy 2012 cited by 160

  18. Ebola Vaccination Using a DNA Vaccine Coated on PLGA‐PLL/γPGA Nanoparticles Administered Using a Microneedle Patch

    Authors: , , , , , - Advanced Healthcare Materials 2016 cited by 120

  19. The Three-Dimensional Structure of Canine Parvovirus and Its Functional Implications

    Authors: , , , , , , , , , , - Science 1991 cited by 513

  20. Vaccination inducing broad and improved cross protection against multiple subtypes of influenza A virus

    Authors: , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2010 cited by 155

  21. Stability of influenza vaccine coated onto microneedles

    Authors: , , , , , , - Biomaterials 2012 cited by 120

  22. Inhibition of Influenza Virus Replication in Tissue Culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): Mechanism of Action

    Authors: , - Journal of General Virology 1976 cited by 368

  23. H1N1 influenza virus infection results in adverse pregnancy outcomes by disrupting tissue-specific hormonal regulation

    Authors: , , , , , - PLoS Pathogens 2017 cited by 122

  24. Improved immunogenicity of individual influenza vaccine components delivered with a novel dissolving microneedle patch stable at room temperature

    Authors: , , , , , , , , , - Drug Delivery and Translational Research 2015 cited by 90